QuantLogix ← CI scorecard
📅 CI Earnings Preview
The Cigna Group
Next report (est.)
April 28, 2026
Countdown
Imminent
EPS growth YoY
+77.2%
Revenue growth YoY
+13.8%
Options-implied earnings move
±5.1%
The at-the-money straddle prices a move to roughly $313.18 or $282.82 from $298.00 by June 18, 2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
October 30, 2025 ±2.5% -17.4% under-priced
July 31, 2025 ±3.0% -10.2% under-priced
May 2, 2025 ±1.9% -0.1% over-priced
October 31, 2024 ±2.0% +0.6% over-priced
August 1, 2024 ±2.0% -4.6% under-priced
May 2, 2024 ±1.4% -3.5% under-priced
November 2, 2023 ±1.5% +3.1% under-priced
August 3, 2023 ±1.9% -3.9% under-priced
Across these reports, options implied an average ±2.0% move vs an actual average of 5.4% — the stock stayed inside the implied band 25% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q4 FY2025 $4.66 $72.5B $1.3B
Q3 FY2025 $6.98 $69.7B $2.0B
Q2 FY2025 $5.71 $67.2B $1.6B
Q1 FY2025 $4.85 $65.5B $1.4B
Live 5-factor engine read: Buy · 61/100 Full scorecard →
Get alerted before every CI report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CI before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

The Cigna Group (CI) reports imminently, with the next report estimated for April 28, 2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 5.4% on average — the market has tended to under-price CI's earnings risk. Fundamentals into the print: EPS up 77.2% year-over-year, revenue up 13.8%. QuantLogix's live 5-factor engine currently reads CI as a buy at 61/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →